Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease

Our data suggests that plasma p-tau217r in addition to Aβ42/40 ratio can significantly improve anti-amyloid clinical trial screening burden and timelines for recruitment.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.090434
Citations
1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease

Robert A. Rissman
1 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
0.33
article

Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease

Robert A. Rissman
article en
1 citations

Abstract

Our data suggests that plasma p-tau217r in addition to Aβ42/40 ratio can significantly improve anti-amyloid clinical trial screening burden and timelines for recruitment.

Alzheimer s & DementiaVol. 20(S1)
University of California San Diego (US)
Openalex Percentile: Top 34%
Alzheimer's disease research and treatments
0.33
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease — Robert A. Rissman · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS